Gasporox AB (publ) (GPX.ST)
Lund, SE
Gasporox AB (publ) is dedicated to developing and bringing to market solutions that utilize laser spectroscopy. Their product range includes the GasSpect series of sensors for headspace analysis and the LeakSpect series, designed to identify carbon dioxide leaks in packaged goods. They also provide MicroLab laboratory instruments for advancing research and development in packaging and materials, alongside the GPX1500, a non-invasive oxygen headspace gas analyzer. Beyond their product offerings, Gasporox also provides specialized measurement services for assessing packages and optimizing processes. The company was established in 2005 and is headquartered in Lund, Sweden.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.25% | -1.82% | -3.57% | +17.39% | +19.82% | +2.02% | +6.30% | -57.26% | -35.71% | -32.40% | -32.40% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-03 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Hardware, Equipment & Parts: +10.0%-7.4% Q1'26: +121.6% (vs Q1'25)
-
EPS growth Hardware, Equipment & Parts: +20.2%-173.3% Q1'26: +65.3% (vs Q1'25)
-
FCF margin FCF growth · Hardware, Equipment & Parts: +27.1%-10.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Hardware, Equipment & Parts: +8.7%-25.3% Q1'26: -22.5% (vs Q1'25)
-
ROIC Hardware, Equipment & Parts: +5.7%-60.4% Q1'26: -39.3% (vs Q1'25)
-
Share dilution Hardware, Equipment & Parts: +0.0%+6.5% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Hardware, Equipment & Parts: -0.70×0.00× Q1'26: -12.34× (vs Q1'25)
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
21.45M
est: 26.97M (-20.5%)
|
31.43M
est: 31.08M (+1.1%)
|
34.10M
est: 35.70M (-4.5%)
|
31.57M
est: 45.50M (-30.6%)
|
61.40M
61.40M – 61.40M
+34.9% YoY
|
73.70M
73.70M – 73.70M
+20.0% YoY
|
| EBITDA |
-3.26M
est: -3.97M (+18.1%)
|
946.0K
est: -4.58M (+120.7%)
|
-347.0K
est: -3.42M (+89.9%)
|
-1.56M
est: -4.36M (+64.3%)
|
-5.88M
-5.88M – -5.88M
-34.9% YoY
|
-7.06M
-7.06M – -7.06M
-20.0% YoY
|
| EBIT |
-4.22M
est: -5.19M (+18.7%)
|
-443.0K
est: -5.98M (+92.6%)
|
-2.00M
est: -6.17M (+67.6%)
|
-7.98M
est: -7.87M (-1.4%)
|
-10.62M
-10.62M – -10.62M
-34.9% YoY
|
-12.74M
-12.74M – -12.74M
-20.0% YoY
|
| Net Income |
-4.56M
|
-1.25M
|
-2.68M
est: -1.87M (-43.1%)
|
-7.71M
est: 935.3K (-924.4%)
|
5.61M
5.61M – 5.61M
+500.0% YoY
|
9.35M
9.35M – 9.35M
+66.7% YoY
|
| SGA |
26.43M
est: 12.39M (+113.3%)
|
—
est: 14.28M (-100.0%)
|
—
est: 12.78M (-100.0%)
|
—
est: 16.29M (-100.0%)
|
21.98M
21.98M – 21.98M
+34.9% YoY
|
26.39M
26.39M – 26.39M
+20.0% YoY
|
| EPS |
-0.53
|
-0.14
|
-0.30
est: -0.20 (-50.0%)
|
-0.82
est: 0.10 (-920.0%)
|
0.60
0.60 – 0.60
+500.0% YoY
|
1.00
1.00 – 1.00
+66.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marta Lewander Xu | Chief Executive Officer | 2M | female |
| Fredrik Hansson | Chief Financial Officer | — | — |
| Hanna Sjostrom | Chief Executive Officer of GPX Medical AB | — | female |
| Roland Koch | Vice President and Director of Sales & Applications | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GPX.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
